KARACHI: Pakistani scientists have made a significant success in the fight against coronavirus pandemic.
Medical sciences experts at Dow University Health Sciences have claimed to have developed intravenous immunoglobulin (IVIg) which will be able to cure a coronavirus patient. The IVIG has been prepared using antibodies from body of the patients who recovered from the viral infection.
The experts of the university have successfully completed trial of immunoglobulin testing and enamel safety. Prof Shaukat said preparation of immunoglobulin was a ray of hope amid the coronavirus crisis.
Vice Chancellor Prof Muhammad Saeed Quraishy called it a very important breakthrough in the war against Covid19.
“This way of treatment is a safe, low risk and highly effective against Coronavirus. Through this method, Immunoglobulin is prepared after separation of antibodies found in the blood of a recovered patient from the corona. This method is considerably different from plasma therapy and it should be noted that the treatment by hyper immunoglobulin (H-IVIG) is approved by the US Federal agency, Food and Drug Administration (FDA), for normal conditions. Plasma therapy, on the other hand, is only allowed in emergencies due to its side effects,” he said.
It may be mentioned that earlier a Punjab University student Hafiz Muzammil had claimed to have developed a vaccination model for coronavirus. His investigative research was published in an international journal. He researched on four essential proteins of coronavirus. All experiments of the vaccine were conducted on computational software and databases.
Hafiz Muzammil is a PhD scholar and is appointed as assistant registrar at Punjab University.
